Published in Women's Health Weekly, November 2nd, 2000
Led by Marc Fenstermacher, MD, a diagnostic radiologist, and John Hazle, PhD, a physicist, both in M.D. Anderson's Department of Diagnostic Radiology, the Phase II clinical trial is open to 15 breast cancer surgical patients with tumors no larger than two centimeters. The study is sponsored by the treatment's developer, TxSonics Inc., of Dallas, Texas.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly